Targeting CD83 for the treatment of graft-versus-host disease.
about
Antibody- and aptamer-strategies for GvHD prevention.The Nucleocapsid Protein and Nonstructural Protein 10 of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Enhance CD83 Production via NF-κB and Sp1 Signaling Pathways.Involvement of Caveolin-1 in CD83 Internalization in Mouse Dendritic Cells.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.Nsp1α of Porcine Reproductive and Respiratory Syndrome Virus Strain BB0907 Impairs the Function of Monocyte-Derived Dendritic Cells via the Release of Soluble CD83
P2860
Targeting CD83 for the treatment of graft-versus-host disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Targeting CD83 for the treatment of graft-versus-host disease.
@en
Targeting CD83 for the treatment of graft-versus-host disease.
@nl
type
label
Targeting CD83 for the treatment of graft-versus-host disease.
@en
Targeting CD83 for the treatment of graft-versus-host disease.
@nl
prefLabel
Targeting CD83 for the treatment of graft-versus-host disease.
@en
Targeting CD83 for the treatment of graft-versus-host disease.
@nl
P2093
P2860
P356
P1476
Targeting CD83 for the treatment of graft-versus-host disease.
@en
P2093
Ming Q Wei
Xiaosong Liu
Xiongfei Wang
P2860
P304
P356
10.3892/ETM.2013.1033
P577
2013-04-02T00:00:00Z